The metabolic syndrome and body composition in childhood cancer survivors by Young Bae Sohn et al.
DOI: 10.3345/kjp.2011.54.6.253 
Korean J Pediatr 2011;54(6):253-259
Original article
253
The metabolic syndrome and body composition in 
childhood cancer survivors
Purpose: Long-term survivors of childhood cancer appear to have 
an increased risk for the metabolic syndrome, subsequent type 2 
diabetes and cardiovascular disease in adulthood compared to healthy 
children. The purpose of this study was to investigate the frequency of 
the metabolic syndrome and associated factors in childhood cancer 
survivors at a single center in Korea. 
Methods: We performed a retrospective review of medical records of 
98 childhood cancer survivors who were diagnosed and completed 
anticancer treatment at Samsung Medical Center, Seoul, Korea 
between Jan. 1996 and Dec. 2007. Parameters of metabolic syndrome 
were evaluated between Jan. 2008 and Dec. 2009. Clinical and 
biochemical findings including body fat percentage were analyzed.  
Results:  A total of 19 (19.4%) patients had the metabolic syndrome. 
The median body fat percentage was 31.5%. The body mass index 
and waist circumference were positively correlated with the cranial 
irradiation dose (r=0.38, P<0.001 and r=0.44, P<0.00, respectively). 
Sixty-one (62.2%) patients had at least one abnormal lipid value. The 
triglyceride showed significant positive correlation with the body fat 
percentage (r=0.26, P=0.03). The high density lipoprotein cholesterol   
showed significant negative correlation with the percent body fat (r=-
0.26, P=0.03).  
Conclusion: Childhood cancer survivors should have thorough 
metabolic evaluation including measurement of body fat percentage 
even if they are not obese. A better understanding of the determinants 
of the metabolic syndrome during adolescence might provide 
preventive interventions for improving health outcomes in adulthood.
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Introduction
Improved diagnostic tools and treatment modalities including 
surgery, chemotherapy and radiation therapy, as well as hematopoietic 
stem cell transplantation have dramatically increased childhood 
cancer survival over the last 30 years
1). As the number of childhood 
cancer survivors grows, quality of life issues over the long term have 
become important. 
The metabolic syndrome is a cluster of features including: dysli-
pidemia, hyperglycemia, hypertension and obesity, especially central 
obesity. The metabolic syndrome is a risk factor for the subsequent 
development of type 2 diabetes and cardiovascular disease. Many 
investigators have reported adolescent prevalence data for the 
metabolic syndrome using numerous diagnostic criteria. Although 
agreement is lacking on the criteria for diagnosing the metabolic 
syndrome in children and adolescents, the diagnostic criteria typically 
involve the same five risk factors identified in adults including 
abdominal obesity, high triglyceride, low high-density lipoprotein 
cholesterol (HDL-C), high blood pressure and high fasting glucose 
with modification of the cut-off values
2-4). 
According to a statement by the American Heart Association, post-
cancer treatment survivors were classified as tier III, which means 
increased cardiovascular risk factors with epidemiological evidence 
for manifest cardiovascular disease early in adult life
5). 
In 1996, Talvensaari et al.
5) reported that long-term survivors of 
childhood cancer appeared to have an increased risk for the metabolic 
syndrome compared to age and gender matched healthy control 
children.  
In Korea, a recent report revealed that the prevalence of the me-
tabolic syndrome in the general childhood population was around 
10%
6). However, study of the metabolic syndrome in childhood 
cancer survivors has not been performed. The purpose of this study 
was to investigate the frequency of the metabolic syndrome and 
associated factors in childhood cancer survivors at a single center in 
Korea. 
Materials and methods
1. Subjects
All surviving 98 subjects who visited endocrinology clinic and were 
examined for parameters of metabolic syndrome between January 
2008 and December 2009 were enrolled in this study. All subjects 
were diagnosed and treated for childhood cancer of less than 18 years 
of age at the Department of Pediatrics, Samsung Medical Center, 
Seoul, Korea, between 1996 and 2007. The clinical characteristics 
of the patients are listed in Table 1. At the time of the examination, 
all survivors were disease free. The study was approved by the 
institutional review board at Samsung Medical Center, Seoul, Korea. 
2. Methods
The medical records were reviewed for the clinical history. The 
patients were interviewed and a physical examination was performed. 
The height and weight were measured. The body mass index (BMI) 
was calculated as the weight in kilograms divided by the height in 
meters squared. Height, weight and BMI standard deviation score 
(SDS) were assessed using the Korean standard growth charts
7). 
Pubertal development was assessed according to Tanner and 
Whitehouse stage
8). Waist and hip circumferences were measured 
to the nearest millimeter. The BMI at or above the 85th percentile 
and below 95th percentile was considered overweight. The BMI 
above the 95th percentile was considered obese
6). The physical 
examination included blood pressure, measured using an automated 
hemadynamometer. Fat mass and percent body fat were determined 
by dual-energy x-ray absorptiometry (DXA, Hologic Delphi W, 
software 12.4.2, Hologic Inc., Bedford, MA, USA). The precision of 
Table 1. Clinical Characteristics of Subjects   
Characteristic Value
Age at evaluation (yr) 11.2±4.9
Time after diagnosis (yr) 5.3±2.9 
Time after end of treatment (yr) 3.9±2.6
Age at diagnosis (yr) 5.9±4.9
Sex (M:F) 61:37 
Diagnosis
Leukemia 31
Intracranial germ cell tumor 23
Medulloblastoma  10
Neuroblastoma 25
Retinoblastoma  5
Others  4
Chemotherapy 98
Cranial irradiation 
No 35
TBI 30
CSRT 33
Total radiation dose (cGy) 3,100 
Cranial irradiation dose (cGy)  1,980
HSCT
  No 36
  Auto-HSCT 36
  Allo-HSCT 26  
Values are presented as mean±SD or number.
TBI, total body irradiation (1,000 cGy); CSRT, craniospinral radiation therapy 
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the fat assessments was approximately 1%.
Laboratory samples were collected in the morning after overnight 
fasting. The tests included plasma triglycerides, plasma total 
cholesterol, serum HDL-C, serum low-density lipoprotein cholesterol 
(LDL-C), blood glucose, serum insulin, plasma uric acid, insulin-
like growth factor 1 (IGF-1), triiodothyronine, free thyroxine, and 
thyroid-stimulating hormone. 
Standard growth hormone provocation test was performed after 
overnight fasting with at least two separate stimuli with insulin, 
glucagon, clonidine or levodopa. Human-growth hormone (hGH) 
was measured in serial blood samples with 30 minute interval during 
2 hours by commercial radioimmunoassay kit (Immunotech S.A.S., 
Marseille Cedex, France). Growth hormone deficiency (GHD) was 
diagnosed when all provocated hGHs were less than 10 ng/mL with 
at least two stimuli. 
The definition reported by the National Cholesterol Education 
Program/Adult Treatment Panel III was used to determine the 
diagnosis of the metabolic syndrome
9). The findings of at least three 
of the following five criteria were required to diagnose the metabolic 
syndrome: Central obesity with a waist circumference at or over 90th 
percentile for age, gender, and height; Low HDL-C levels, ≤40 mg/
dL; high triglyceride (TG) levels, ≥110 mg/dL; high fasting glucose, 
≥110 mg/dL; elevated systolic or diastolic blood pressure, at or above 
the 90th percentile for age, gender, and height. 
3. Statistical analysis
Continuous data were analyzed using an independent sample 
t-test or analysis of variance in the case of normally distributed data 
and the Mann-Whitney U-test or Kruskal-Wallis test for skewed 
distribution or ordinal variables. Categorized data were analyzed 
using Fisher’s exact test and the chi-square test as appropriate. To 
determine independent association of clinical parameters and 
metabolic syndrome prevalence, data were analyzed using multiple 
logistic regression test. A P value <0.05 was considered significant; all 
statistical analyses were performed using SPSS ver. 15.0 (SPSS Inc., 
Chicago. IL, USA).
Results
1. Metabolic syndrome prevalence 
A total of 19 (19.4%) patients had the metabolic syndrome (Table 
2). Fourteen were males and five were females. Their median age 
was 15 years. The median BMI SDS was 0.71. The median body fat 
percent was 31.5%. Among them, seven (36.8%) were overweight 
or obese. Therefore, half of them had the metabolic syndrome even 
though they were not overweight or obese. Seventeen (89.5%) patients 
had cranial irradiation. Four (21%) patients had GHD, which was 
diagnosed by a growth hormone stimulation test. All four patients 
with GHD had cranial irradiation. 
By multivariate analyses BMI SDS (P=0.03), the presence of GHD 
(P=0.04), and the type of cranial irradiation (P<0.001) were found 
associated with metabolic syndrome prevalence.
2. Obesity 
Seventeen (17.3%) patients were overweight or obese. Thirteen 
(13.3%) patients were overweight and 4 (4%) were obese. Central 
obesity was found in 13 (13.3%) patients. Subgroups classified 
according to the type of cranial irradiation showed significant 
differences in the BMI and waist circumference. However, there 
was no significant difference in the BMI SDS, waist circumference 
percentile or body fat percent (Table 3). Patients with GHD had 
higher BMI and increased waist circumference (Table 3). Among 
the parameters of obesity, the BMI and waist circumference were 
positively correlated with the cranial irradiation dose (r=0.38, P<0.001 
and r=0.44, P<0.001, respectively, Fig. 1). 
 All 98 patients showed euthyroid state which include 24 patients 
with levo-thyroxine therapy at the time of the present study due to 
overt hypothyroidsm. The level of mean serum IGF-1 was 226±169 
ng/mL and IGF-1 SDS was -0.13±1.59. The mean IGF-1 SDS of 
Table 2. Prevalence of Metabolic Syndrome Traits 
Prevalence, n (%)
Metabolic syndrome 19/98 (19.4)
Waist circumference ≥90th percentile 13/98 (13.3)
Triglycerides ≥110 mg/dL 57/98 (58.2)
HDL-C ≤40 mg/dL 25/98 (25.5)
Fasting glucose level ≥110 mg/dL 19/98 (19.4)
Blood pressure ≥90th percentile 26/98 (26.5)
HDL-C, high-density lipoprotein cholesterol.
Table 3. Clinical Parameters of Metabolic Syndrome  
BMI 
(kg/m
2, n=98) 
17.5±3.9
Body fat
(%, n=63)
(M/F, 31.5/32.7)
Waist circumference 
(cm, n=98) 
64.7±12.6
Median   P value Median   P value Median     P value
Cranial irradiation              <0.01                  <0.01
No (n=35) 16.2      28.8        0.14 59.0        
TBI (n=30)  16.0 30.5 66.0
CSRT (n=33) 17.1 32.2 71.4
GHD                0.01                  <0.01
No (n=69) 17.0       30.0        0.08 62.0        
Yes (n=29) 19.7 32.4 69.0
BMI, body mass index; TBI, total body irradiation (1,000 cGy); CSRT, 
craniospinral radiation therapy (≥3,000 cGy); GHD, growth hormone 
deficiency.256      YB Sohn, et al. • The metabolic syndrome in childhood cancer survivors 
patients with GHD was not significantly lower than that of patients 
without GHD (-0.54±2.15 vs. 0.03±1.26, respectively, P=0.18). 
3. Body composition
The percent of whole body fat was measured in 63 patients (42 
males and 21 females). The median body fat percent was 31.5%. The 
median body fat percent in males and females was 31.5% (26.6 to 
35.6) and 32.7% (27.3 to 34.8) respectively (Table 3). The percent 
body fat tended to be higher in patients that had cranial irradiation 
with higher doses. In addition, the percent body fat tended to be 
higher in patient with GHD compared to patients without GHD 
(Table 3).
4. Lipid profile
In total, 61 (62.2%) patients had at least one abnormal lipid 
value. Twenty two (21.4%) patients had hypercholesterolemia (total 
cholesterol ≥200 mg/dL), 14 (14.3%) had raised LDL-C (LDL-C 
≥130 mg/dL), 25 (25.5%) had reduced HDL-C (HDL-C ≤40 mg/
dL) and 57 (58.2%) had hypertriglyceridemia (TG ≥110 mg/dL) 
(Table 2). 
There was no significant difference in the lipid profile between 
patients with and without cranial irradiation. The TG showed 
significant positive correlation with the percent body fat (r=0.26, 
P=0.03, Fig. 2A). Moreover, the HDL-C showed significant negative 
correlation with the percent body fat (r= -0.26, P=0.03, Fig. 2B).  
5. Glucose metabolism
The fasting glucose was above 110 mg/dL in 19 (19.4%) patients. 
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Fig. 1. Correlation of cranial irradiation and obesity. The body mass index (BMI) (A) and waist circumference (B) 
were positively correlated with the cranial irradiation dose (r=0.38, P<0.001 and r=0.44, P<0.001, respectively).
T
r
i
g
l
y
c
e
r
i
d
e
 
(
m
g
/
d
L
)
20.0 30.0 40.0 50.0
Body fat (%)
0
100
200
300
400
500
600 r=0.26
P=0.03
H
D
L
-
C
 
(
m
g
/
d
L
)
20.0 30.0 40.0 50.0
Body fat (%)
20
30
40
50
60
70
80 r=-0.26
P=0.03
A B
Fig. 2. (A) Correlation of body fat percentage and triglyceride. The triglyceride showed significant positive 
correlation with the body fat percentage. (B) Correlation of body fat percentage and triglyceride. The high-density 
lipoprotein cholesterol (HDL-C) showed significant negative correlation with the body fat percentage.Korean J Pediatr 2011;54(6):253-259 • DOI: 10.3345/kjp.2011.54.6.253    257
Subgroups classified according to the type of cranial irradiation 
showed significant differences in the fasting glucose level (Table 4). 
6. Hypertension
Twenty six (26.5%) patients had increased blood pressure (Table 2). 
Eighteen were males and eight were females. Their median age was 
12.2 years (5.3 to 15). The median age at diagnosis was 3.8 years (1.5 
to 9.6). The median BMI SDS was 0.23 (-0.43 to 0.79). The median 
percent body fat was 31.8% (28.9 to 34.3). Sixteen (61.5%) had 
cranial irradiation. 
Discussion
The metabolic syndrome is an important health issue in children 
and adolescents with regard to the long term implications of 
cardiovascular morbidity and type 2 diabetes. This is one of a few 
reports to examine the frequency and factors associated with the 
metabolic syndrome among childhood cancer survivors in Korea. 
The results of this study showed that the frequency of the metabolic 
syndrome in childhood cancer survivors was 19.4%. This is about 
twice the frequency in the general population of children according 
to a study conducted by the Korean national health and nutrition 
survey
10).
Several studies have reported an increased prevalence of overweight 
or obese childhood cancer survivors
1,11,12). The reported prevalence 
of overweight or obese childhood cancer survivors has varied from 
16 to 50%
5,13,14). In this study, 17.3% were overweight or obese, 
which is consistent with previous studies. This is a higher frequency 
compared to the prevalence in the general Korean population, which 
has recently been reported to be around 10%
6). Moreover, our results 
show that BMI SDS was positively associated with prevalence of 
metabolic syndrome. Therefore, continuous surveillance of BMI in 
childhood cancer survivor is crucial for early detection of metabolic 
syndrome in these patients. 
The basic feature of the metabolic syndrome is central obesity. 
An appropriate definition of central obesity for children and 
adolescents is challenging. Central obesity was found in 13.2% 
of the patients reported here, which is consistent with previous 
studies
15). In this study, the BMI and waist circumference percentiles 
were correlated with the cranial irradiation dose, which could have 
caused hypothalamic/pituitary damage that manifested as hormonal 
problems. Growth hormone has been implicated not only in linear 
growth, but also in metabolism. The results of this study showed that 
the percent body fat of patients with GHD tended to be higher than 
in patients without GHD. 
The amount of fat and lean body mass, and the distribution of fat 
are important risk factors for the prediction of cardiovascular disease 
and type 2 diabetes
16,17). Unfortunately, there is no Korean reference 
data for body composition in this age group. Therefore, the reported 
reference data of percent body fat was used
12,18). Higgins et al.
19) 
reported that an upper cut-off point of 33% body fat is an indicator of 
cardiovascular disease risk in children. In this study, 41.2% (26/63) of 
the patients had a percent fat that was above 33%, despite a median 
BMI SDS of 0.14 (-0.71 to 0.9). This may suggest that the body 
composition of childhood cancer survivors should be considered even 
if they are not overweight or obese.
About half of the patients in this study had at least one abnormal 
lipid profile. The percent body fat was positively correlated with the 
triglyceride and negatively correlated with the HDL-C. Vatanparast 
et al.
20) reported that DXA-derived fat mass indices can be used for 
predicting blood lipid profiles in postmenopausal women. Although 
studies in children are lacking, our findings suggest the importance 
of the percent fat in predicting the lipid profile.
In childhood cancer survivors, the frequency of the metabolic 
syndrome appears to be increased. This finding was associated with 
BMI SDS, presence of GHD, and cranial irradiation. The notable 
Table 4. Laboratory Parameters of Metabolic Syndrome
Cholesterol (mg/dL) HDL-C (mg/dL) LDL-C (mg/dL) TG (mg/dL) Fasting glucose (mg/dL)
Median       P value Median       P value Median      P value Median      P value Median       P value
Cranial irradiation                   0.425                    0.06                    0.16                      0.05                    0.03*
No (n=35) 166            57    92   98   95
TBI (n=30) 171 56   95 143 101
CSRT (n=33) 172 49 107 125   99
GHD                   0.60                     0.74                   0.42                    0.60                    0.57
No (n= 69) 177.5  51.0 105.5 120    99 
Yes (n=29) 178.5 51.5   95.5 115   95
Total, median (range)       171 (156-189)       53.5 (39-68)         97 (83-124)       127 (80-184)         98 (90-107)
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; TBI, total body irradiation (1,000 cGy); CSRT, 
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fact was that the body composition of childhood cancer survivors 
was metabolically unfavorable even if they were not obese. Therefore, 
childhood cancer survivors should have thorough metabolic 
evaluation including measurement of the percent body fat even if their 
BMI is in the normal range. Furthermore, more intense surveillance 
and education is necessary for the patients who had cranial irradiation 
and GHD. 
The major limitations of this study are as follows: a cross-sectional 
setting, small sample size from a single center and lack of optimal 
comparison group. Thereafter, a prospective long-term cohort study is 
needed to reproduce the results of this study. 
In Korea, the number of childhood cancer survivors increased to 
approximately 20,000 to 25,000
21). However, there are no large cohort 
studies in Korea like The Childhood Cancer Survivor Study of USA 
or British Childhood Cancer Survivor Study of United Kingdom. 
In 2008, Children’s Oncology Group published the update of Long-
Term Follow-up Guidelines for Survivors of Childhood, Adolescent, 
and Young Adult Cancers
22) for screening and management of late 
effects resulting from therapeutic exposures during the treatment 
of malignancies. The guideline recommends annual physical 
examination of height, weight, BMI, blood pressure for screening 
metabolic syndrome. Moreover, laboratory tests including fasting 
blood glucose, insulin, and lipid profile are recommended every 2 
years if the patient is overweight or every 5 years if the patient is in 
normal weight
22). Now, we need the Korean cancer survivor cohort 
and follow-up guidelines. The primary preventive interventions for 
the patients with risk factors of metabolic syndrome include education 
of the patients and parents about the diet modification and adequate 
physical activities for maintaining normal BMI and body fat percent. 
In conclusion, a better understanding of the determinants of the 
metabolic syndrome during adolescence might provide insights into 
preventive interventions for improving health outcomes and reducing 
the incidence of cardiovascular disease in adults. 
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